A Randomized Controlled Trial Comparing the Incidence of Surgical Site Infections in Cesarean Section With and Without Subcutaneous Drain Placement at Queen Savang Vadhana Memorial Hospital
1 other identifier
interventional
86
1 country
1
Brief Summary
To study and compare the incidence of surgical site infection after cesarean section in pregnant women with subcutaneous wound drainage and those without subcutaneous wound drainage at Queen Savang Vadhana Memorial Hospital, Sriracha. Chonburi Thailand
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedFirst Submitted
Initial submission to the registry
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
February 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedFebruary 9, 2026
February 1, 2026
2 months
January 13, 2026
February 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome
To compare the incidence of surgical site infection after cesarean section in pregnant women with and without subcutaneous wound drainage.
14 days
Secondary Outcomes (1)
Length of hospital stay
14 days
Study Arms (2)
Intervention group
EXPERIMENTALPregnant women undergoing cesarean section with placement of a subcutaneous wound drain.
Control group
NO INTERVENTIONPregnant women undergoing cesarean section without placement of a subcutaneous wound drain.
Interventions
In the intervention group, a subcutaneous wound drain is placed using a closed suction Redivac drain (10-14 French). The drain is inserted into the subcutaneous layer above the surgical incision through a skin exit site located 2-3 cm from the wound edge, avoiding visible vessels to reduce bleeding. A trocar is used to guide placement, ensuring the drain lies transversely beneath and covers the entire length of the incision. The drain is secured to the skin with silk sutures, connected to a Redivac suction system to apply negative pressure, and covered with a sterile dressing after skin closure to reduce the risk of contamination.
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Able to communicate in Thai
- Undergoing cesarean section, both elective and emergency procedures
- Subcutaneous fat thickness ≥ 4 cm, measured preoperatively using a standardized ultrasound technique
- Able to return for postpartum follow-up at Somdech Phra Boromrajthevi Hospital, Sriracha
- Willing to participate in the study and able to provide written informed consent
You may not qualify if:
- Pregnant women with chronic immunosuppressive conditions, such as systemic lupus erythematosus (SLE), HIV infection, severe anemia (Hb \< 10.0 g/dL), or uncontrolled diabetes
- Presence of skin disease or skin infection at the abdominal surgical site
- Evidence of infection prior to cesarean section
- Abnormal bleeding disorders requiring specialized treatment
- History of allergy to, or complications from, the use of wound drainage systems
- Refusal to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Queen Savang vadhana Memmorial Hospital
Chon Buri, Changwat Chon Buri, 20110, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 13, 2026
First Posted
February 9, 2026
Study Start
June 1, 2025
Primary Completion
July 31, 2025
Study Completion
March 31, 2026
Last Updated
February 9, 2026
Record last verified: 2026-02